Novo Nordisk Clinical Trial Call Center

Chicago, Illinois 60637

0 studies enrolling now · 3 studies all time

What they study most

Acquired Bleeding Disorder, Crohn's Disease, Diabetes, Diabetes Mellitus, Type 2, Inflammation, Trauma

Studies at this site

• Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease — Completed
• Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™) — Completed
• Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma — Withdrawn before enrolling